Chemotherapy Container Articles & Analysis: Older
2 articles found
In the same year, Trodelvy received accelerated approval from the FDA for a second indication in patients with locally advanced or metastatic urothelial cancer after treatment with platinum-containing chemotherapy and a PD-1 or PD-L1 inhibitor. Trodelvy consists of a humanized monoclonal IgG (designated hRS7) that binds Trop-2. ...
The biologics license application (BLA) has been accepted for Enfortumab Vedotin for the treatment of locally advanced or metastatic urothelial carcinoma in patients who have previously received PD-1/PD-L1 inhibitors and platinum-containing chemotherapy. Enfortumab Vedotin is the first domestically submitted targeted antibody-drug conjugate that specifically ...